FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3040295629> ?p ?o ?g. }

• W3040295629 endingPage "32" @default.
• W3040295629 startingPage "20" @default.
• W3040295629 abstract "Pleomorphic xanthoastrocytoma (PXA) is a rare astrocytoma predominantly affecting children and young adults. We performed comprehensive genomic characterization on a cohort of 67 patients with histologically defined PXA (n = 53, 79%) or anaplastic PXA (A-PXA, n = 14, 21%), including copy number analysis (ThermoFisher Oncoscan, n = 67), methylation profiling (Illumina EPIC array, n = 43) and targeted next generation sequencing (n = 32). The most frequent alterations were CDKN2A/B deletion (n = 63; 94%) and BRAF p.V600E (n = 51, 76.1%). In 7 BRAF p.V600 wild-type cases, alternative driver alterations were identified involving BRAF, RAF1 and NF1. Downstream phosphorylation of ERK kinase was uniformly present. Additional pathogenic alterations were rare, with TERT, ATRX and TP53 mutations identified in a small number of tumors, predominantly A-PXA. Methylation-based classification of 46 cases utilizing a comprehensive reference tumor allowed assignment to the PXA methylation class in 40 cases. A minority grouped with the methylation classes of ganglioglioma or pilocytic astrocytoma (n = 2), anaplastic pilocytic astrocytoma (n = 2) or control tissues (n = 2). In 9 cases, tissue was available from matched primary and recurrent tumors, including 8 with anaplastic transformation. At recurrence, two tumors acquired TERT promoter mutations and the majority demonstrated additional non-recurrent copy number alterations. Methylation class was preserved at recurrence. For 62 patients (92.5%), clinical follow-up data were available (median follow-up, 5.4 years). Overall survival was significantly different between PXA and A-PXA (5-year OS 80.8% vs. 47.6%; P = 0.0009) but not progression-free survival (5-year PFS 59.9% vs. 39.8%; P = 0.05). WHO grade remained a strong predictor of overall survival when limited to 38 cases defined as PXA by methylation-based classification. Our data confirm the importance of WHO grading in histologically and epigenetically defined PXA. Methylation-based classification may be helpful in cases with ambiguous morphology, but is largely confirmatory in PXA with well-defined morphology." @default.
• W3040295629 created "2020-07-10" @default.
• W3040295629 creator A5002148403 @default.
• W3040295629 creator A5002801148 @default.
• W3040295629 creator A5008648693 @default.
• W3040295629 creator A5010625614 @default.
• W3040295629 creator A5013513088 @default.
• W3040295629 creator A5020307029 @default.
• W3040295629 creator A5021419381 @default.
• W3040295629 creator A5023410987 @default.
• W3040295629 creator A5031000945 @default.
• W3040295629 creator A5031595426 @default.
• W3040295629 creator A5032385201 @default.
• W3040295629 creator A5037771197 @default.
• W3040295629 creator A5046123788 @default.
• W3040295629 creator A5050894746 @default.
• W3040295629 creator A5060720802 @default.
• W3040295629 creator A5069689120 @default.
• W3040295629 creator A5077968996 @default.
• W3040295629 date "2020-08-04" @default.
• W3040295629 modified "2023-10-14" @default.
• W3040295629 title "Biology and grading of pleomorphic xanthoastrocytoma—what have we learned about it?" @default.
• W3040295629 cites W1987824662 @default.
• W3040295629 cites W1990079979 @default.
• W3040295629 cites W1999166815 @default.
• W3040295629 cites W2077463410 @default.
• W3040295629 cites W2081182312 @default.
• W3040295629 cites W2101870168 @default.
• W3040295629 cites W2115078134 @default.
• W3040295629 cites W2117131162 @default.
• W3040295629 cites W2122004774 @default.
• W3040295629 cites W2122481654 @default.
• W3040295629 cites W2122769974 @default.
• W3040295629 cites W2129915465 @default.
• W3040295629 cites W2146267855 @default.
• W3040295629 cites W2152779165 @default.
• W3040295629 cites W2152871663 @default.
• W3040295629 cites W2166152141 @default.
• W3040295629 cites W2167810957 @default.
• W3040295629 cites W2171965424 @default.
• W3040295629 cites W2432271591 @default.
• W3040295629 cites W2460793474 @default.
• W3040295629 cites W2520236800 @default.
• W3040295629 cites W2561818048 @default.
• W3040295629 cites W2587703250 @default.
• W3040295629 cites W2737907665 @default.
• W3040295629 cites W2761086339 @default.
• W3040295629 cites W2772104082 @default.
• W3040295629 cites W2777181847 @default.
• W3040295629 cites W2787816121 @default.
• W3040295629 cites W2791150552 @default.
• W3040295629 cites W2793894310 @default.
• W3040295629 cites W2802818144 @default.
• W3040295629 cites W2803003012 @default.
• W3040295629 cites W2883010822 @default.
• W3040295629 cites W2884908336 @default.
• W3040295629 cites W2894102714 @default.
• W3040295629 cites W2941228120 @default.
• W3040295629 cites W3015188401 @default.
• W3040295629 doi "https://doi.org/10.1111/bpa.12874" @default.
• W3040295629 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8018001" @default.
• W3040295629 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32619305" @default.
• W3040295629 hasPublicationYear "2020" @default.
• W3040295629 type Work @default.
• W3040295629 sameAs 3040295629 @default.
• W3040295629 citedByCount "25" @default.
• W3040295629 countsByYear W30402956292020 @default.
• W3040295629 countsByYear W30402956292021 @default.
• W3040295629 countsByYear W30402956292022 @default.
• W3040295629 countsByYear W30402956292023 @default.
• W3040295629 crossrefType "journal-article" @default.
• W3040295629 hasAuthorship W3040295629A5002148403 @default.
• W3040295629 hasAuthorship W3040295629A5002801148 @default.
• W3040295629 hasAuthorship W3040295629A5008648693 @default.
• W3040295629 hasAuthorship W3040295629A5010625614 @default.
• W3040295629 hasAuthorship W3040295629A5013513088 @default.
• W3040295629 hasAuthorship W3040295629A5020307029 @default.
• W3040295629 hasAuthorship W3040295629A5021419381 @default.
• W3040295629 hasAuthorship W3040295629A5023410987 @default.
• W3040295629 hasAuthorship W3040295629A5031000945 @default.
• W3040295629 hasAuthorship W3040295629A5031595426 @default.
• W3040295629 hasAuthorship W3040295629A5032385201 @default.
• W3040295629 hasAuthorship W3040295629A5037771197 @default.
• W3040295629 hasAuthorship W3040295629A5046123788 @default.
• W3040295629 hasAuthorship W3040295629A5050894746 @default.
• W3040295629 hasAuthorship W3040295629A5060720802 @default.
• W3040295629 hasAuthorship W3040295629A5069689120 @default.
• W3040295629 hasAuthorship W3040295629A5077968996 @default.
• W3040295629 hasBestOaLocation W30402956292 @default.
• W3040295629 hasConcept C104317684 @default.
• W3040295629 hasConcept C121608353 @default.
• W3040295629 hasConcept C126322002 @default.
• W3040295629 hasConcept C142724271 @default.
• W3040295629 hasConcept C143998085 @default.
• W3040295629 hasConcept C2776689207 @default.
• W3040295629 hasConcept C2777722931 @default.
• W3040295629 hasConcept C2778024855 @default.
• W3040295629 hasConcept C2778227246 @default.

• next